Works matching DE "IRBESARTAN"

Results: 210

Biochemical effects of irbesartan in experimental diabetic nephropathy.

Published in:

Indian Journal of Pharmacology, 2009, v. 41, n. 6, p. 252, doi. 10.4103/0253-7613.59922

By:

Vaishya, Richa;
Singh, J.;
Lal, Harbans

Publication type:

Article

Novel Synthesis and Characterization of Irbesartan Derivative an Anti‐Hypertensive Active Pharmaceutical Ingredient (API).

Published in:

Macromolecular Symposia, 2024, v. 413, n. 1, p. 1, doi. 10.1002/masy.202300008

By:

Tomar, Divya Rana;
Jayakumar, S. Venkatesan;
Saxena, Amit

Publication type:

Article

Effect of irbesartan on development of atrial fibrosis and atrial fibrillation in a canine atrial tachycardia model with left ventricular dysfunction, association with p53.

Published in:

Heart & Vessels, 2016, v. 31, n. 12, p. 2053, doi. 10.1007/s00380-016-0853-7

By:

Kataoka, Naoya;
Nishida, Kunihiro;
Kinoshita, Koshi;
Sakamoto, Tamotsu;
Nakatani, Yosuke;
Tsujino, Yasushi;
Mizumaki, Koichi;
Inoue, Hiroshi;
Kinugawa, Koichiro

Publication type:

Article

Combined effects of irbesartan and carvedilol on expression of tissue factor and tissue factor pathway inhibitor in rats after myocardial infarction.

Published in:

Heart & Vessels, 2011, v. 26, n. 6, p. 646, doi. 10.1007/s00380-010-0106-0

By:

Yu, Junmin;
Zhao, Jiyi;
Liu, Wei;
Ge, Zhenzhong;
Du, Yongli

Publication type:

Article

Effect of Irbesartan treatment on plasma and urinary markers of protein damage in patients with type 2 diabetes and microalbuminuria.

Published in:

Amino Acids, 2012, v. 42, n. 5, p. 1627, doi. 10.1007/s00726-011-0857-7

By:

Rabbani, Naila;
Adaikalakoteswari, Antonysunil;
Rossing, Kasper;
Rossing, Peter;
Tarnow, Lise;
Parving, Hans-Henrik;
Thornalley, Paul

Publication type:

Article

Rational Design and Characterization of Transdermal Patch of Irbesartan for Hypertension.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2020, v. 54, p. 464, doi. 10.5530/ijper.54.3s.145

By:

Dubey, Roshan Kumar;
Dewangan, Hitesh Kumar

Publication type:

Article

Simultaneous Determination of Sartans by High Performance Liquid Chromatography with Ultra Violet Detection.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2017, v. 51, n. 2, p. 343, doi. 10.5530/ijper.51.2.41

By:

Maslarska, Vania;
Yankov, Vladimir;
Obreshkova, Danka;
Bozhanov, Stanislav

Publication type:

Article

IRBESARTAN DISSOLUTION ENHANCEMENT USING PEG-BASED SOLID DISPERSIONS: THE EFFECT OF PEG MOLECULAR WEIGHTS.

Published in:

Farmacia, 2017, v. 65, n. 4, p. 537

By:

BOLOURCHIAN, NOUSHIN;
FASHAMI, FATEMEH MIRZAYEH;
FOROUTAN, SEYED MOHSEN

Publication type:

Article

Validating an Automated Sample Preparation/LC-MS-MS Analysis for Nitrosamines in Irbesartan and Metformin.

Published in:

LC-GC Europe, 2020, v. 33, n. 12, p. 620

By:

Liscio, Camilla

Publication type:

Article

Understanding the molecular-pharmaceutical basis of sartan recalls focusing on valsartan.

Published in:

Global Cardiology Science & Practice, 2020, v. 2020, n. 2, p. 1, doi. 10.21542/gcsp.2020.25

By:

Ray, Avik;
Atal, Shubham;
Sadasivam, Balakrishnan

Publication type:

Article

A Time to Pause and Reflect: When a Patient with Autoimmune Hepatitis Stops Responding to Corticosteroids.

Published in:

2016

By:

Tsang, Lewis;
Fadia, Mitali;
Chitturi, Shivakumar

Publication type:

Case Study

Efficacy and safety of early versus late titration of fixed-dose Irbesartan/hydrochlorothiazide: ACTUAL study.

Published in:: Blood Pressure, 2012, v. 21, n. 1, p. 69, doi. 10.3109/08037051.2012.654697
Publication type:: Article

Irbesartan restored aquaporin-1 levels via inhibition of NF-kB expression in acute kidney injury model.

Published in:

Nefrologia, 2024, v. 44, n. 4, p. 540, doi. 10.1016/j.nefro.2023.11.005

By:

Candan, Busra;
Ilhan, Ilter;
Sarman, Emine;
Sevimli, Murat

Publication type:

Article

The importance of perioperative and complication management in the treatment of pheochromocytoma crisis with venoarterial extracorporeal membrane oxygenation (V-A ECMO): a case report and review of the literature.

Published in:

Perfusion, 2023, v. 38, n. 2, p. 228, doi. 10.1177/02676591211049314

By:

Chen, Jiayi;
Jin, Guangyong;
Zhu, Ying;
Hu, Wei;
He, Huadong;
Wang, Changrong;
Cai, Xueying

Publication type:

Article

Pharmacokinetic-pharmacodynamic relationships of three angiotensin II receptor antagonists in normal volunteers.

Published in:

Kidney International Supplement, 1996, n. 55, p. S-24

By:

BURNIER, MICHEL;
BUCLIN, THIERRY;
BIOLLAZ, JÉRÔME;
NUSSBERGER, JURG;
WAEBER, BERNARD;
BRUNNER, HANS R.

Publication type:

Article

Economic evaluation of irbesartan in combination with hydrochlorothiazide in the treatment of hypertension in Greece.

Published in:

European Journal of Health Economics, 2011, v. 12, n. 3, p. 253, doi. 10.1007/s10198-010-0243-5

By:

Maniadakis, Nikos;
Ekman, Mattias;
Fragoulakis, Vasilios;
Papagiannopoulou, Vasiliki;
Yfantopoulos, John

Publication type:

Article

Sparsentan in immunoglobulin A nephropathy: a profile of its use.

Published in:

Drugs & Therapy Perspectives, 2024, v. 40, n. 3, p. 101, doi. 10.1007/s40267-024-01058-9

By:

Heo, Young-A;
Kang, Connie

Publication type:

Article

Initial angiotensin receptor blockade-induced decrease in albuminuria is associated with long-term renal outcome in type 2 diabetic patients with microalbuminuria: a post hoc analysis of the IRMA-2 trial.

Published in:: Current Medical Literature: Diabetes, 2011, v. 28, n. 4, p. 154
Publication type:: Article

Management - Complications and Comorbidities.

Published in:: Current Medical Literature: Diabetes, 2010, v. 27, n. 1, p. 31
Publication type:: Article

Management - Complications and Comorbidities.

Published in:: Current Medical Literature: Diabetes, 2009, v. 26, n. 4, p. 108
Publication type:: Article

Determination of antihypertensive drugs irbesartan and doxazosin mesylate in healthcare products and urine samples using surface-enhanced Raman scattering.

Published in:

Analytical & Bioanalytical Chemistry, 2022, v. 414, n. 27, p. 7813, doi. 10.1007/s00216-022-04315-w

By:

Ding, Yanru;
Zhang, Nan;
Zhao, Junqi;
Lv, Haiyang;
Wang, Xu;
Zhao, Bing;
Tian, Yuan

Publication type:

Article

Virtual Screening of Novel 24-Dehydroxysterol Reductase (DHCR24) Inhibitors and the Biological Evaluation of Irbesartan in Cholesterol-Lowering Effect.

Published in:

Molecules, 2023, v. 28, n. 6, p. 2643, doi. 10.3390/molecules28062643

By:

Wang, Haozhen;
Lu, Ziyin;
Li, Yang;
Liu, Ting;
Zhao, Linlin;
Gao, Tianqi;
Lu, Xiuli;
Gao, Bing

Publication type:

Article

Cyclodextrin Complexed Lipid Nanoparticles of Irbesartan for Oral Applications: Design, Development, and In Vitro Characterization.

Published in:

Molecules, 2021, v. 26, n. 24, p. 7538, doi. 10.3390/molecules26247538

By:

Dudhipala, Narendar;
Ettireddy, Swetha;
Youssef, Ahmed Adel Ali;
Puchchakayala, Goverdhan

Publication type:

Article

Simultaneous Analysis of Irbesartan and Hydrochlorothiazide: An Improved HPLC Method with the Aid of a Chemometric Protocol.

Published in:

Molecules, 2012, v. 17, n. 3, p. 3461, doi. 10.3390/molecules17033461

By:

Vujić, Zorica;
Mulavdić, Nedžad;
Smajić, Miralem;
Brborić, Jasmina;
Stankovic, Predrag

Publication type:

Article

The Effect of Combined Antihypertensive Treatment (Felodipine with Either Irbesartan or Metoprolol) on Erectile Function: A Randomized Controlled Trial.

Published in:

Cardiology, 2013, v. 125, n. 4, p. 235, doi. 10.1159/000350955

By:

Yang, Longquan;
Yu, Jing;
Ma, Ruixin;
Zhao, Feng;
Lin, Xin;
Liu, Peijun;
Hu, Hao;
Bai, Feng

Publication type:

Article

Randomized multicentre pilot study of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: United Kingdom Heart and Renal Protection (HARP)- III—rationale, trial design and baseline data.

Published in:

Nephrology Dialysis Transplantation, 2017, v. 32, n. 12, p. 2043, doi. 10.1093/ndt/gfw321

By:

Haynes, Richard

Publication type:

Article

Irbesartan delays progression of nephropathy as measured by estimated glomerular filtration rate: post hoc analysis of the Irbesartan Diabetic Nephropathy Trial.

Published in:

Nephrology Dialysis Transplantation, 2012, v. 27, n. 6, p. 2255, doi. 10.1093/ndt/gfr696

By:

Evans, Marc;
Bain, Stephen C.;
Hogan, Simon;
Bilous, Rudy W.

Publication type:

Article

Irbesartan treatment does not influence plasma levels of the advanced glycation end products Nɛ(1-carboxymethyl)lysine and Nɛ(1-carboxyethyl)lysine in patients with type 2 diabetes and microalbuminuria. A randomized controlled trial.

Published in:

Nephrology Dialysis Transplantation, 2011, v. 26, n. 11, p. 3573, doi. 10.1093/ndt/gfr102

By:

Engelen, Lian;
Persson, Frederik;
Ferreira, Isabel;
Rossing, Peter;
Hovind, Peter;
Teerlink, Tom;
Stehouwer, Coen D.;
Parving, Hans-Henrik;
Schalkwijk, Casper G.

Publication type:

Article

Adverse drug reactions: Keratoacanthoma development after systemic administration with irbesartan/hydrochlorothiaZide.

Published in:

Medical Review / Meditsinski Pregled, 2022, v. 58, n. 3, p. 55

By:

Tchernev, G.;
Oliveira, N.;
Kandathil, L. J.;
Valchkov, T.;
Batashki, I.

Publication type:

Article

Voltammetric Detection of Irbesartan by Molecularly Imprinted Polymer (MIP)-Modified Screen-Printed Electrodes.

Published in:

Chemosensors, 2022, v. 10, n. 12, p. 517, doi. 10.3390/chemosensors10120517

By:

Zanoni, Camilla;
Rovida, Riccardo;
Magnaghi, Lisa Rita;
Biesuz, Raffaela;
Alberti, Giancarla

Publication type:

Article

Comparative bioavailability of a newly developed irbesartan 300 mg containing preparation.

Published in:

Hospital Pharmacology: International Multidisciplinary Journal, 2018, v. 5, n. 2, p. 638, doi. 10.5937/hpimj1802638P

By:

Petrov, Andrey D.;
Gatchev, Emil M.;
Kalinov, Krasimir B.;
Filipova, Elena P.;
Uzunova, Katya H.;
Vekov, Toni Y.

Publication type:

Article

Correlation of CyPA with Chronic Renal Failure.

Published in:

Journal of Kunming Medical University / Kunming Yike Daxue Xuebao, 2014, v. 35, n. 11, p. 58

By:

XU Jian;
ZHOU Xiao-ping;
LUO Hui-min;
MENG Hu;
YUAN Hong-ling;
XIONG Li-yan

Publication type:

Article

Prospective direct comparison of antihypertensive effect and safety between high-dose amlodipine or indapamide in hypertensive patients uncontrolled by standard doses of angiotensin receptor blockers and amlodipine.

Published in:

Clinical & Experimental Hypertension, 2018, v. 40, n. 2, p. 99, doi. 10.1080/10641963.2017.1334798

By:

Okamura, Keisuke;
Shirai, Kazuyuki;
Totake, Nao;
Okuda, Tetsu;
Urata, Hidenori

Publication type:

Article

Combined treatment of irbesartan and diltiazem ameliorates endothelium dependent vasodilatation in hypertensives.

Published in:

Clinical & Experimental Hypertension, 2017, v. 39, n. 7, p. 612, doi. 10.1080/10641963.2017.1306537

By:

Zhou, Tingting;
Huang, Xiaodong;
Cai, Xiaoqi;
Xie, Liangdi

Publication type:

Article

Effect of single-pill irbesartan/amlodipine combination-based therapy on clinic and home blood pressure profiles in hypertension with chronic kidney diseases.

Published in:

Clinical & Experimental Hypertension, 2016, v. 38, n. 8, p. 744, doi. 10.1080/10641963.2016.1200063

By:

Kobayashi, Ryu;
Tamura, Kouichi;
Wakui, Hiromichi;
Ohsawa, Masato;
Azushima, Kengo;
Haku, Sona;
Uneda, Kazushi;
Ohki, Kohji;
Haruhara, Kotaro;
Kinguchi, Sho;
Umemura, Satoshi

Publication type:

Article

Influence of initial angiotensin receptor blockers on treatment persistence in uncomplicated hypertension: A nation-wide population-based study.

Published in:

Clinical & Experimental Hypertension, 2016, v. 38, n. 3, p. 325, doi. 10.3109/10641963.2015.1116548

By:

Ah, Young-Mi;
Lee, Ju-Yeun;
Choi, Yun-Jung;
Kong, Jisun;
Kim, Baegeum;
Choi, Kyung Hee;
Han, Nayoung;
Yu, Yun Mi;
Oh, Jung Mi;
Shin, Wan Gyoon;
Lee, Hae-Young

Publication type:

Article

The therapeutic advantage of combination antihypertensive drug therapy using amlodipine and irbesartan in hypertensive patients: Analysis of the post-marketing survey data from PARTNER (Practical combination therapy of Amlodin and angiotensin II Receptor blocker; safety and efficacy in patients with hypertension) study

Published in:

Clinical & Experimental Hypertension, 2015, v. 37, n. 7, p. 542, doi. 10.3109/10641963.2015.1026037

By:

Ishimitsu, Toshihiko;
Fukuda, Hirofumi;
Uchida, Masako;
Ishibashi, Kazushi;
Sato, Fusako;
Nukui, Kazuhiko;
Nagao, Munehiko

Publication type:

Article

Combining irbesartan and trichlormethiazide enhances blood pressure reduction via inhibition of sympathetic activity without adverse effects on metabolism in hypertensive rats with metabolic syndrome.

Published in:

Clinical & Experimental Hypertension, 2015, v. 37, n. 1, p. 33, doi. 10.3109/10641963.2014.897719

By:

Nishihara, Masaaki;
Hirooka, Yoshitaka;
Sunagawa, Kenji

Publication type:

Article

Comparison of the Efficacy and Safety of Irbesartan and Olmesartan in Patients With Hypertension (EARTH Study).

Published in:

Clinical & Experimental Hypertension, 2012, v. 34, n. 5, p. 342, doi. 10.3109/10641963.2012.683912

By:

Morii, Joji;
Miura, Shin-ichiro;
Shiga, Yuhei;
Sugihara, Makoto;
Arimura, Tadaaki;
Sako, Hideto;
Zhang, Bo;
Uehara, Yoshinari;
Saku, Keijiro

Publication type:

Article

Effects of Lisinopril, Irbesartan, and Amlodipine on the Thrombogenic Variables in the Early and Late Stages of the Treatment in Hypertensive Patients.

Published in:

Clinical & Experimental Hypertension, 2012, v. 34, n. 2, p. 145, doi. 10.3109/10641963.2011.577491

By:

Tiryaki, Ozlem;
Usalan, Celalettin;
Buyukhatipoglu, Hakan;
Sayiner, Zeynel Abidin;
Kilisli, Hasan

Publication type:

Article

Comparison of the Antihypertensive Efficacy of Irbesartan///HCTZ and Valsartan///HCTZ Combination Therapy: Impact of Age and Gender.

Published in:

Clinical & Experimental Hypertension, 2010, v. 32, n. 8, p. 499, doi. 10.3109/10641963.2010.496509

By:

Asmar, Roland;
Oparil, Suzanne

Publication type:

Article

Safety and Tolerability of Fixed-Dose Irbesartan//Hydrochlorothiazide for Rapid Control of Severe Hypertension.

Published in:

Clinical & Experimental Hypertension, 2009, v. 31, n. 7, p. 572, doi. 10.3109/10641960902929420

By:

Neutel, Joel M.;
Franklin, Stanley S.;
Bhaumik, Amitabha;
Lapuerta, Pablo;
Oparil, Suzanne

Publication type:

Article

Role of Irbesartan in Prevention of Post-Coronary Artery Bypass Graft Atrial Fibrillation.

Published in:

American Journal of Cardiovascular Drugs, 2011, v. 11, n. 4, p. 277, doi. 10.2165/11587160-000000000-00000

By:

El-Haddad, Mohamed A.;
Zalawadiya, Sandip K.;
Awdallah, Hany;
Sabet, Sameh;
El-Haddad, Haitham A.;
Mostafa, Ashraf;
Rashed, Ahmed;
El-Naggar, Wael;
Farag, Nabil;
Saleb, Mohamed A.;
Jacob, Sony

Publication type:

Article

Cost Effectiveness of Angiotensin Receptor Blocker Monotherapy in Patients with Hypertension in the Netherlands: A Comparative Analysis Using Clinical Trial and Drug Utilization Data.

Published in:

American Journal of Cardiovascular Drugs, 2010, v. 10, n. 1, p. 49, doi. 10.2165/11319570-000000000-00000

By:

Boersma, Cornelis;
Voors, Adriaan A.;
Visser, Sipke T.;
de Jong-van den Berg, Lolkje T. W.;
Postma, Maarten J.

Publication type:

Article

Protective effect of irbesartan, an angiotensin II receptor antagonist, alone and in combination with aspirin on middle cerebral artery occlusion model of focal cerebral ischemia in rats.

Published in:

Human & Experimental Toxicology, 2011, v. 30, n. 5, p. 354, doi. 10.1177/0960327110371257

By:

Pratap, Ravi;
Pillai, K. K.;
Khanam, Razia;
Islam, Fakhrul;
Shibli Jameel Ahmad;
Akhtar, Mohammad

Publication type:

Article

A Prospective Multicenter Clinical Trial of Chinese Herbal Formula JZQG (Jiangzhuoqinggan) for Hypertension.

Published in:

American Journal of Chinese Medicine, 2013, v. 41, n. 1, p. 33, doi. 10.1142/S0192415X13500031

By:

Tong, Xiao-Lin;
Lian, Feng-Mei;
Zhou, Qiang;
Xu, Li-Peng;
Ji, Hang-Yu;
Xu, Gui-Cheng;
Hu, Yuan-Hui;
Zhao, Lin-Hua;
Xia, Le;
Wang, Jia;
Chen, Xin-Yan;
Chan, Man-Hon;
Zhang, Lan-Lan;
Gao, Wen;
Zhen, Zhong;
Zhou, Shui-Ping;
Chang, Bai

Publication type:

Article

Euonymus alatus in the Treatment of Diabetic Nephropathy in Rats.

Published in:

American Journal of Chinese Medicine, 2012, v. 40, n. 6, p. 1177, doi. 10.1142/S0192415X12500875

By:

Chang, Bai;
Jin, Chuan;
Zhang, Wei;
Kong, Li;
Yang, Ju-Hong;
Lian, Feng-Mei;
Li, Qiao-Fen;
Yu, Bo;
Liu, Wen-Ke;
Yang, Ling-Ling;
Zhao, Ping;
Zhen, Zhong

Publication type:

Article

A case of idiopathic angioedema exacerbated by angiotensin receptor blocker administration.

Published in:

International Journal of Dermatology, 2017, v. 56, n. 12, p. 1504, doi. 10.1111/ijd.13675

By:

Haga, Naoya;
Nishie, Wataru;
Morita, Yusuke;
Mizuno, Osamu;
Ohguchi, Yuka;
Shimizu, Hiroshi

Publication type:

Article

The antihypertensive effect of irbesartan in spontaneously hypertensive rats is associated with improvement of the leptin–adiponectin imbalance.

Published in:

Adipocyte, 2021, v. 10, n. 1, p. 101, doi. 10.1080/21623945.2021.1886409

By:

Weng, Junting;
Chen, Min;
Guo, Rongjie;
Yang, Shuzhen;
Liu, Danjuan;
Fang, Dexiang

Publication type:

Article

Irbesartan Ameliorates Lipid Deposition by Enhancing Autophagy via PKC/AMPK/ULK1 Axis in Free Fatty Acid Induced Hepatocytes.

Published in:

Frontiers in Physiology, 2019, p. N.PAG, doi. 10.3389/fphys.2019.00681

By:

He, Juan;
Ding, Jian;
Lai, Qiuhua;
Wang, Xinke;
Li, Aimin;
Liu, Side

Publication type:

Article